{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:35:30Z","timestamp":1773020130470,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,22]]},"DOI":"10.7759\/cureus.10598","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T02:39:51Z","timestamp":1600828791000},"source":"Crossref","is-referenced-by-count":4,"title":["Clinical, Histopathological and Outcome Analysis of Five Patients With Lichenoid Eruption Following Anti-Tumor Necrosis Factor-Alpha Therapy for Ankylosing Spondylitis: Report of One Case and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Samily","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Helder Costa","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel Pereira Benevides","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Judith Vieira","family":"Corr\u00eaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Ewerton Maia","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/03009740902922612","article-title":"Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors","volume":"38","author":"Exarchou SA","year":"2009","unstructured":"Exarchou SA, Voulgari PV, Markatseli TE, Zioga A, Drosos AA. Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Scand J Rheumatol. 2009, 38:328-31. 10.1080\/03009740902922612","journal-title":"Scand J Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.01.009","article-title":"Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease","volume":"7","author":"Mocci G","year":"2013","unstructured":"Mocci G, Marzo M, Papa A, Armuzzi A, Guidi L. Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease. J Crohns Colitis. 2013, 7:769-79. 10.1016\/j.crohns.2013.01.009","journal-title":"J Crohns Colitis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07682.x","article-title":"Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists","volume":"156","author":"Lee HH","year":"2007","unstructured":"Lee HH, Song IH, Friedrich M, et al.. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol. 2007, 156:486-91. 10.1111\/j.1365-2133.2007.07682.x","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.09.032","article-title":"Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-\u03b1 antagonists","volume":"61","author":"Asarch A","year":"2009","unstructured":"Asarch A, Gottlieb AB, Lee J, et al.. Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-\u03b1 antagonists. J Am Acad Dermatol. 2009, 61:104-11. 10.1016\/j.jaad.2008.09.032","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0839","article-title":"Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: a relevant class-effect","volume":"90","author":"Garcovich S","year":"2010","unstructured":"Garcovich S, Burlando M, Rongioletti F, Garcovich A, Parodi A, Amerio P. Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: a relevant class-effect. Acta Derm Venereol. 2010, 90:311-2. 10.2340\/00015555-0839","journal-title":"Acta Derm Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-011-8262-2","article-title":"Skin manifestations induced by TNF-alpha inhibitors in juvenile idiopathic arthritis","volume":"42","author":"Pontikaki I","year":"2012","unstructured":"Pontikaki I, Shahi E, Frasin LA, Gianotti R, Gelmetti C, Gerloni V, Mero PL. Skin manifestations induced by TNF-alpha inhibitors in juvenile idiopathic arthritis. Clin Rev Allergy Immunol. 2012, 42:131-4. 10.1007\/s12016-011-8262-2","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.138.9.1258","article-title":"Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern","volume":"138","author":"Vergara G","year":"2002","unstructured":"Vergara G, Silvestre JF, Betlloch I, Vela P, Albares MP, Pascual JC. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol. 2002, 138:1258-9.","journal-title":"Arch Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2012.07.017","article-title":"Lichen planus under anti TNF therapy for ankylosing spondylitis","volume":"80","author":"Wendling D","year":"2013","unstructured":"Wendling D, Biver-Dalle C, Vidon C, Prati C, Aubin F. Lichen planus under anti TNF therapy for ankylosing spondylitis. Joint Bone Spine. 2013, 80:227-8.","journal-title":"Joint Bone Spine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0193","article-title":"Psoriasiform drug eruptions under anti-TNF treatment of arthritis are not true psoriasis","volume":"87","author":"Seneschal J","year":"2007","unstructured":"Seneschal J, Lepreux S, Bouyssou-Gauthier ML, et al.. Psoriasiform drug eruptions under anti-TNF treatment of arthritis are not true psoriasis. Acta Derm Venereol. 2007, 87:77-80. 10.2340\/00015555-0193","journal-title":"Acta Derm Venereol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.5070\/D32FW0W71N","article-title":"Letter: lichenoid eruption induced by etanercept","volume":"18","author":"Barrientos N","year":"2012","unstructured":"Barrientos N, Garc\u00eda-S\u00e1nchez S, Dom\u00ednguez JD. Letter: lichenoid eruption induced by etanercept. Dermatol Online J. 2012, 18:15.","journal-title":"Dermatol Online J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/ar1724","article-title":"Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study","volume":"7","author":"Flendrie M","year":"2005","unstructured":"Flendrie M, Vissers WH, Creemers MC, de Jong EM, de Kerkhof PC, van Riel PL. Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther. 2005, 7:666-76. 10.1186\/ar1724","journal-title":"Arthritis Res Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1249","article-title":"Successful treatment of lichen planus with adalimumab","volume":"92","author":"Holl\u00f3 P","year":"2012","unstructured":"Holl\u00f3 P, Szakonyi J, Kiss D, Jokai H, Horv\u00e1th A, K\u00e1rpati S. Successful treatment of lichen planus with adalimumab. Acta Derm Venereol. 2012, 92:385-6. 10.2340\/00015555-1249","journal-title":"Acta Derm Venereol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2015.09.058","article-title":"The type I interferons: basic concepts and clinical relevance in immune-mediated inflammatory diseases.","volume":"576(1 Pt 1)","author":"de Padilla CM","year":"2016","unstructured":"de Padilla CM, Niewold TB. The type I interferons: basic concepts and clinical relevance in immune-mediated inflammatory diseases.. Gene. 2016, 576(1 Pt 1):14-21. 10.1016\/j.gene.2015.09.058","journal-title":"Gene"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2016.2898","article-title":"Lichenoid drug eruption caused by adalimumab: a case report and literature review","volume":"27","author":"Inoue A","year":"2017","unstructured":"Inoue A, Sawada Y, Yamaguchi T, et al.. Lichenoid drug eruption caused by adalimumab: a case report and literature review. Eur J Dermatol. 2017, 27:69-70. 10.1684\/ejd.2016.2898","journal-title":"Eur J Dermatol"},{"key":"ref15","article-title":"Lichenoid reactions in association with tumor necrosis factor alpha inhibitors: a review of the literature and addition of a fourth lichenoid reaction","volume":"8","author":"McCarty M","year":"2015","unstructured":"McCarty M, Basile A, Bair B, Fivenson D. Lichenoid reactions in association with tumor necrosis factor alpha inhibitors: a review of the literature and addition of a fourth lichenoid reaction. J Clin Aesthet Dermatol. 2015, 8:45-9.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12768","article-title":"Case report of lichen planopilaris occurring in a pediatric patient receiving a tumor necrosis factor \u03b1 inhibitor and a review of the literature","volume":"33","author":"Jayasekera PS","year":"2016","unstructured":"Jayasekera PS, Walsh ML, Hurrell D, Parslew RA. Case report of lichen planopilaris occurring in a pediatric patient receiving a tumor necrosis factor \u03b1 inhibitor and a review of the literature. Pediatr Dermatol. 2016, 33:143-6. 10.1111\/pde.12768","journal-title":"Pediatr Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2016.2860","article-title":"Pigmented lichenoid drug eruption: a new clinical presentation of interface dermatitis induced by anti-TNF alpha drugs","volume":"26","author":"Darrigade AS","year":"2016","unstructured":"Darrigade AS, Goussot JF, Milpied B, Taieb A, Seneschal J. Pigmented lichenoid drug eruption: a new clinical presentation of interface dermatitis induced by anti-TNF alpha drugs. Eur J Dermatol. 2016, 26:633-4. 10.1684\/ejd.2016.2860","journal-title":"Eur J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-3680-2","article-title":"Oral lichen planus in IBD patients: a paradoxical adverse effect of anti-TNF-\u03b1 therapy","volume":"60","author":"Andrade P","year":"2015","unstructured":"Andrade P, Lopes S, Albuquerque A, Os\u00f3rio F, Pardal J, Macedo G. Oral lichen planus in IBD patients: a paradoxical adverse effect of anti-TNF-\u03b1 therapy. Dig Dis Sci. 2015, 60:2746-9. 10.1007\/s10620-015-3680-2","journal-title":"Dig Dis Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.12816\/0008295","article-title":"Adalimumab-induced lichenoid drug eruption","volume":"62","author":"El Habr C","year":"2014","unstructured":"El Habr C, Meguerian Z, Sammour R. Adalimumab-induced lichenoid drug eruption. J Med Liban. 2014, 62:238-40. 10.12816\/0008295","journal-title":"J Med Liban"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.01.003","article-title":"Oral lichen planus after certolizumab pegol treatment in a patient with Crohn\u2019s disease","volume":"5","author":"Mocciaro F","year":"2011","unstructured":"Mocciaro F, Orlando A, Renna S, Rizzuto MS, Cottone M. Oral lichen planus after certolizumab pegol treatment in a patient with Crohn\u2019s disease. J Crohn\u2019s Colitis. 2011, 5:173-4. 10.1016\/j.crohns.2011.01.003","journal-title":"J Crohn\u2019s Colitis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/26388-clinical-histopathological-and-outcome-analysis-of-five-patients-with-lichenoid-eruption-following-anti-tumor-necrosis-factor-alpha-therapy-for-ankylosing-spondylitis-report-of-one-case-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:05Z","timestamp":1707506825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/26388-clinical-histopathological-and-outcome-analysis-of-five-patients-with-lichenoid-eruption-following-anti-tumor-necrosis-factor-alpha-therapy-for-ankylosing-spondylitis-report-of-one-case-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.10598","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,22]]}}}